JILL SEELY: Open Payments
NPI 1194058974 · WARRINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,630 in 77 payments from 18 companies in 2025. Trend: 2023 $104 · 2024 $1,153 · 2025 $1,630
Food & beverage: $1,533Education: $97
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $316 |
| Regeneron Healthcare Solutions, Inc. | 8 | $299 |
| Janssen Biotech, Inc. | 10 | $166 |
| GENZYME CORPORATION | 5 | $146 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| LEO Pharma Inc. | 4 | $79 |
| UCB, Inc. | 3 | $76 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $71 |
| Organon LLC | 7 | $52 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, COSENTYX, Bimzelx, ADBRY, ILUMYA.
Industry payments across PA — which companies pay providers there.
